Letter from the Editor in Chief
- PMID: 35949647
 - PMCID: PMC9359422
 - DOI: 10.19102/icrm.2022.130707
 
Letter from the Editor in Chief
Conflict of interest statement
Dr. Mansour reports the reception of research grants from Abbott Laboratories, Biosense Webster, Johnson & Johnson, Boston Scientific, Medtronic, Pfizer, Boehringer Ingelheim, and SentreHeart. He is also a consultant for Abbott Laboratories, Biosense Webster, Johnson & Johnson, Boston Scientific, Janssen, Medtronic, Phillips, Novartis, and SentreHeart and reports an equity relationship with EPS Solutions. All aforementioned relationships are in the area of atrial fibrillation; Dr. Mansour additionally reports an equity relationship in the area of ventricular fibrillation with NewPace Ltd.
References
Publication types
LinkOut - more resources
Full Text Sources